--- title: "Is Herbalife (HLF) Undervalued After Its Fuel Like Ronaldo Recovery Push?" type: "News" locale: "en" url: "https://longbridge.com/en/news/293125179.md" description: "Herbalife (HLF) is considered undervalued, with a fair value estimate of $18.33 against a recent close of $11.99, driven by analyst expectations of moderate revenue growth and firmer margins. Despite the 'Fuel Like Ronaldo' campaign boosting visibility, the stock has faced recent pressure. Analyst consensus targets $18.33, though opinions range from $9.0 to $25.0. Key risks include regulatory scrutiny of its MLM model and skepticism regarding supplement claims." datetime: "2026-07-19T13:05:59.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293125179.md) - [en](https://longbridge.com/en/news/293125179.md) - [zh-HK](https://longbridge.com/zh-HK/news/293125179.md) generator: "portal-rs" --- # Is Herbalife (HLF) Undervalued After Its Fuel Like Ronaldo Recovery Push? Herbalife (HLF) has expanded its global Fuel Like Ronaldo campaign with detailed post match recovery guidance, introducing a 4 R framework that links nutrition and hydration choices to athletic recovery and future performance readiness. See our latest analysis for Herbalife. Despite the Fuel Like Ronaldo campaign raising Herbalife’s profile, the stock has come under pressure lately, with the share price falling over the past week and three months. The 1 year total shareholder return remains positive but has been weaker over three and five years. If this kind of sports focused story has your attention, it can be worth widening your search to see which other companies are standing out in the market, starting with 18 top founder-led companies After Herbalife’s recent pullback, the stock trades well below both analyst targets and some intrinsic value estimates, creating a wide valuation gap. Where does a fair value range realistically sit within that spread? ## Most Popular Narrative: 34.6% Undervalued Based on the most followed narrative, Herbalife's fair value sits at $18.33, well above the last close at $11.99, with that gap tied to long term earnings assumptions. > *The analysts have a consensus price target of $18.33 for Herbalife based on their expectations of its future earnings growth, profit margins and other risk factors.* > > *However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $25.0, and the most bearish reporting a price target of just $9.0.* *Read the complete narrative.* Read the complete narrative. Curious what sits behind that valuation gap? The narrative leans on moderate revenue growth, firmer margins, and a future earnings multiple that still assumes a higher required return. The exact mix of those inputs is where the story gets interesting. **Result: Fair Value of $18.33 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, there are still clear risks, including rising regulatory scrutiny of Herbalife’s multi level marketing model and ongoing skepticism toward processed supplements and nutritional claims. Find out about the key risks to this Herbalife narrative. ## Next Steps With Herbalife drawing both optimism around potential rewards and concern about risks, it makes sense to move quickly to test the story against the numbers yourself using 3 key rewards and 3 important warning signs ## Looking for more investment ideas beyond Herbalife? If Herbalife has sharpened your interest in stock picking, broaden your watchlist now with focused ideas that could otherwise stay off your radar. - Target potential mispricing by scanning companies that combine quality with attractive valuations using the 47 high quality undervalued stocks. - Strengthen your income stream by reviewing companies that feature robust payout profiles through the 8 dividend fortresses. - Dial down portfolio stress by focusing on companies that score well on resilience via the 82 resilient stocks with low risk scores. *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.* ### Valuation is complex, but we're here to simplify it. Discover if Herbalife might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.** Access Free Analysis ### Related Stocks - [HLF.US](https://longbridge.com/en/quote/HLF.US.md) ## Related News & Research - [Herbalife (HLF) On Raised 2026 Guidance And CFO Change Looks Undervalued](https://longbridge.com/en/news/296128007.md) - [Herbalife to Present and Host 1x1 Investor Meetings at Midwest IDEAS Investor Conference on August 26 | HLF Stock News](https://longbridge.com/en/news/295787262.md) - [13:33 ETBucked Up® Launches Hunt: Orange Cream, a Limited-Edition Flavor Built to Fuel Your Hunt](https://longbridge.com/en/news/296523042.md) - [Herbalife Q2 adjusted EPS misses estimates on FX headwinds](https://longbridge.com/en/news/295009232.md) - [Nike Is Back at Its 2014 Price and Still Isn’t Cheap, and Wall Street Expects Earnings to Fall Another 18%](https://longbridge.com/en/news/296639305.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**